๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Induction of anticentromere antibody in patients receiving treatment with D-penicillamine

โœ Scribed by Haberhauer, G.

Publisher
Springer-Verlag
Year
1989
Tongue
English
Weight
381 KB
Volume
67
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

D-penicillamine treatment of lung involv
D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma)
โœ Thomas A. Medsger Jr. ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 194 KB ๐Ÿ‘ 2 views

D-penicillamine has been used to treat systemic sclerosis (scleroderma) for nearly two decades. Improvement in cutaneous fibrosis in patients treated with this drug has been documented in a number of uncontrolled studies (1). The effect of D-penicillamine on established visceral involvement due to s

Pharmacokinetics of reduced d-penicillam
Pharmacokinetics of reduced d-penicillamine in patients with rheumatoid arthritis
โœ Michael Butler; George Carruthers; Manfred Harth; David Freeman; John Percy; Dal ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 503 KB

Penicillamine (pp dimethylcysteine, 3 mercaptovaline) is a trifunctional amino acid with carboxyl, amino, and sufhydryl groups. The D-isomer is a remittive agent of similar efficacy to gold in the treatment of persistent rheumatoid arthritis (I). Despite the widespread use of the drug, little infor